Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

The oversight of autonomous artificial intelligence: lessons from nurse practitioners as physician extenders.

PMID: 35968225 ·

W, a, l, k, e, r, , M, o, r, r, e, l, l, ;, , C, a, r, m, e, l, , S, h, a, c, h, a, r, ;, , A, n, t, h, o, n, y, , P, , W, e, i, s, s

JournalJournal of law and the biosciences
Year
PMID35968225

Abstract

The development of autonomous artificial intelligence (A-AI) products in health care raises novel regulatory challenges, including how to ensure their safety and efficacy in real-world settings. Supplementing a device-centered regulatory scheme with a regulatory scheme that considers A-AI products as a 'physician extender' may improve the real-world monitoring of these technologies and produce other benefits, such as increased access to the services offered by these products. In this article, we

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑